You are here

Article Text

Article menu
Download PDFPDF
Clinical and epidemiological research
Concise report
PADI4 polymorphism predisposes male smokers to rheumatoid arthritis
  1. Yuta Kochi1,
  2. Mohamed M Thabet2,
  3. Akari Suzuki1,
  4. Yukinori Okada3,
  5. Nina A Daha2,
  6. René E M Toes2,
  7. Tom W J Huizinga2,
  8. Keiko Myouzen1,
  9. Michiaki Kubo1,
  10. Ryo Yamada4,
  11. Yusuke Nakamura5,
  12. Kazuhiko Yamamoto3
  1. 1Center for Genomic Medicine (CGM), RIKEN, Yokohama, Japan
  2. 2Leiden University Medical Center, Leiden, The Netherlands
  3. 3Graduate School of Medicine, the University of Tokyo, Tokyo, Japan
  4. 4Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan
  5. 5Institute of Medical Science, the University of Tokyo, Tokyo, Japan
  1. Correspondence to Dr Yuta Kochi, Laboratory for Autoimmune Diseases, CGM, RIKEN, 7-3-1 Hongo, Bunkyo-Ku, Tokyo 113-0033, Japan; ykochi{at}src.riken.jp

Abstract

Objective To elucidate the differential role of peptidyl arginine deiminase 4 (PADI4) polymorphism in rheumatoid arthritis (RA) between Asian and European populations, possible gene–environmental interactions among the PADI4 polymorphism, sex and smoking status were analysed.

Methods Three independent sets of case–control samples were genotyped for single-nucleotide polymorphisms in PADI4; Japanese samples (first set, 1019 RA patients, 907 controls; second set, 999 RA patients, 1128 controls) using TaqMan assays and Dutch samples (635 RA patients, 391 controls) using Sequenom MassARRAY platform. The association of PADI4 with RA susceptibility was evaluated by smoking status and sex in contingency tables and logistic regression models.

Results In the first set of Japanese samples, PADI4 polymorphism (rs1748033) showed a greater risk in men (ORallele 1.39; 95% CI 1.10 to 1.76; ptrend=0.0054) than in women and in ever-smokers (ORallele 1.25; 95% CI 1.02 to 1.53; ptrend=0.032) than in never-smokers. Moreover, the highest risk was seen in male ever-smokers (ORallele 1.46; 95% CI 1.12 to 1.90; ptrend=0.0047). Similar trends were observed in the second set of Japanese samples as well as in Dutch samples.

Conclusion PADI4 polymorphism highly predisposes male smokers to RA, and the genetic heterogeneity observed between Asian and European populations may be partly explained by differences in smoking prevalence among men.

http://dx.doi.org/10.1136/ard.2010.130526

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Funding This work was supported by grants from the CGM, RIKEN; the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Leading Project); the Dutch Arthritis Foundation; the Center for Medical Systems Biology and the European Union Sixth Framework Programme.

    • Competing interests None.

    • Patient consent Obtained.

    • Ethics approval This study was conducted with the approval of the ethics committee of RIKEN and Leiden University.

    • Provenance and peer review Not commissioned; externally peer reviewed.